NUVEEN INS CA PREM IMF (NYSE: NPC)

View Portfolio
Back to Investopedia
Back to Investopedia




$13.05 0.00 (0.00%)
Real-time 12:00:00 AM ET
 Turn On
KEY STATS
52-Week High Price
13.88
52-Week Low Price
11.10
Avg Volume (3 Mo.)
0.00 M
Market Cap
0.08 B
P/E Ratio (TTM)
0.0
Diluted EPS (TTM)
0.00
Shares
6.46 M
Dividend Rate ($) / (%)
0.78/6.00
50%
50%
You need to upgrade your Flash Player to view the graph.
View by Date Range:
12 Mo. Price Change : 3% - NPC has underperformed the S&P 500 by 23%
SIMILAR COMPANIES
NameCurrent Price - Today's ChangeMarket Cap
PIMCO ETF TR 1-3 YR TRSY (TUZ) $50.45 -  $0.02(0.03%)0.09 B
PROSHARES ULTR SMCNDCTR (USD) $27.41 -  $0.26(0.96%)0.09 B
WISDOMTREE JAPAN TOTL DV (DXJ) $40.07 -  $0.15(0.38%)0.09 B
VAN KAMPEN MER OH QU MUN (VOQ) $14.90 -  $0.06(0.40%)0.09 B
SPDR DJ GLBL REAL ESTATE (RWO) $29.68 -  $0.01(0.02%)0.08 B
BLACKROCK STRTGC BOND TR (BHD) $12.09 -  $0.20(1.68%)0.08 B
FIRST TR ACTV DIVDND INM (FAV) $12.43 -  $0.66(5.61%)0.08 B
BLUE CHIP VALUE FUND INC (BLU) $2.93 -  $0.04(1.36%)0.08 B
HOLDRS BROADBAND (BDH) $10.69 -  $0.03(0.27%)0.08 B
CORNERSTONE STRATEGIC VA (CLM) $11.92 -  $0.06(0.50%)0.08 B
As of February 09, 2010 at 11:50 AM ET
STOCK ANALYSIS
There are currently no Stock Analysis.
NPC RELATED HEADLINES
arrow
Sector Snap: Regional Banks mostly fall

Forbes.com 11/17/2008
arrow
Sharp-witted elderly shed insight on dementia

Forbes.com 11/16/2008
arrow
Nextrials and Allon Therapeutics Set New Benchmark for Releasing Clinical Trial Results
Nextrials and Allon Therapeutics Set New Benchmark for Releasing Clinical Trial Results
At BusinessWire 6/16/2008
View All Headlines
Stock Simulator- Free Account
Chart Advisor- Free Report
Sponsored Links
COLOSIM2